Outcome and Predictive Factors of Mortality in Hospitalized HIV-Patients in Burkina Faso
- First Online:
- 74 Downloads
The aim of this study was to describe the clinical presentation and predictors of death in a HIV population hospitalized in Ouagadougou, Burkina Faso.
Materials and Methods:
Baseline demographics, viro-immunological status, clinical presentations, and outcome have been analyzed by univariate analysis and a multivariate model.
A total of 1,071 hospitalizations of HIV-positive patients was recorded between 1 January, 2004 and 31 August, 2006, the majority of whom were female (64.1%). The baseline CD4 cell count/μl was higher in the female patients than in the male ones (166.1 vs 110.9). Gastroenteric symptoms were the first cause of hospitalization (61.7%). The crude mortality rate was higher in males than females (38% vs 25.3%). Baseline World Health Organization clinical stage IV (OR 9.22), neurological syndrome (OR 3.04) or wasting syndrome at admission (OR 2.9), positive malaria film (OR 2.17), and an older age independently predicted death. Weight at admission > 40 kg and a higher platelet count at admission were independently associated with a better outcome.
Females are admitted to hospital earlier than males, probably as an indirect result of the Prevention of Mother-to-Child Transmission (PMTCT) public health initiative. An active search of HIV status in other members of the family (PMTCT-plus) may result in the detection of asymptomatic HIV-infected patients as well. A Plasmodium falciparum-positive smear during admission significantly impacted on outcome as well as low platelet count.
Unable to display preview. Download preview PDF.
- 1.WHO, UNICEF, UNAIDS: Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections. December 2006 update. http://www.who.int/GlobalAtlas/predefinedReports/EFS2006/EFS_PDFs/EFS2006_BF.pdf (accessed 26 January 2008).
- 2.UNAIDS: 2007 AIDS epidemic update. Available at: http://www.unaids.org. Accessed 26 January 2008.
- 3.WHO/HIV/2005.02 Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance African region. http://www.who.int/hiv/pub/guidelines/casedefinitions/en/index.html (accessed 26 January 2008).
- 4.Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC). Tuberculosis Coalition for Technical Assistance, The Hague, 2006. http://who.int/tb/publications/2006/istc_report.pdf (accessed 26 January 2008).
- 5.WHO (2003) Revision. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. http://who.int/3by5/publications/documents/arv_guidelines/en/ (accessed 26 January 2008).
- 8.WHO-UNAIDS May 2007. Guidance on provider-initiated HIV testing and counseling in health facilities. http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf (accessed 26 January 2008).
- 9.Grant AD, Djomand G, Smets P, Kadio A, Coulibaly M, Kakou A, Maurice C, Whitaker JP, Sylla-Koko F, Bonard D, Wiktor SZ, Hayes RJ, De Cock KM, Greenberg AE: Profound immunosuppression across the spectrum of opportunistic disease among hospitalised HIV-infected adults in Abidjan, Côte d’Ivoire. AIDS 1997; 11: 1357–1364.PubMedCrossRefGoogle Scholar
- 11.Tansuphasawadikul S, Amornkul PN, Tanchanpong C, Limpakarnjanarat K, Kaewkungwal J, Likanonsakul S, Eampokalap B, Naiwatanakul T, Kitayaporn D, Young NL, Hu DJ, Mastro TD: Clinical presentation of hospitalised adult patients with HIV infection and AIDS in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999; 21: 326–332.PubMedGoogle Scholar
- 15.Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Hondé M, Beaumel A, Kestens L, Kadio A: Contributions of tuberculosis to slim disease in Africa. Br Med J 1994; 308: 1531–1534.Google Scholar
- 17.Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M: Tuberculosis control in the era of HIV. Nature 2005; 5: 819–826.Google Scholar